Microtubule-Associated Protein 4 Is a Prognostic Factor and Promotes Tumor Progression in Lung Adenocarcinoma

Table 1

Correlation between MAP4 protein expression level and clinicopathological variables of patients with lung adenocarcinoma.

Variables	N	MAP4 expression (%)		χ^2	value
		High	Low
Gender				0.10	0.75
Male	49	30 (61.22)	19 (38.78)
Female	42	21 (50.00)	21 (50.00)
Age (year)				2.69	0.10
≤60	40	23 (57.50)	17 (42.50)
>60	51	28 (54.90)	23 (45.10)
Differentiation				4.45	0.03
Well/moderate	65	36 (55.38)	29 (44.62)
Poor	26	15 (57.69)	11 (42.31)
pT				8.10	<0.01
T1-2	69	40 (57.97)	29 (42.03)
T3-4	22	11 (50.00)	11 (50.00)
pN				3.45	0.06
N0	38	20 (52.63)	18 (47.37)
N1-3	53	31 (58.49)	22 (41.51)
TNM stage				9.31	<0.01
I	29	14 (48.28)	15 (51.72)
II-III	62	37 (59.68)	25 (40.32)

N: number; MAP4: microtubule-associated protein 4; p: pathological staging; TNM: tumor-node-metastasis.